Αποτελέσματα Αναζήτησης
16 Ιουλ 2021 · These guidelines bring in the most recent guidance on HIV testing strategies - the entry point for HIV prevention and treatment - and include comprehensive guidance on infant diagnosis. Key recommendations are presented on rapid antiretroviral therapy (ART) initiation and the use of dolutegravir.
- Global HIV Programme - World Health Organization (WHO)
Testing and diagnostics are critical components of the...
- HIV and AIDS - World Health Organization (WHO)
HIV is spread from the body fluids of an infected person,...
- Consolidated guidelines on HIV prevention, testing, treatment, service ...
These consolidated guidelines on HIV prevention, testing,...
- Updated recommendations on first-line and second-line antiretroviral ...
Update on recommendations on antiretroviral regimens for...
- Global HIV Programme - World Health Organization (WHO)
16 Ιουλ 2021 · These consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring bring together existing and new clinical and programmatic recommendations across different ages, populations and settings, bringing together all relevant WHO guidance on HIV produced since 2016.
1 Ιαν 2018 · Update on recommendations on antiretroviral regimens for treating and preventing HIV infection: In 2016, WHO published the consolidated guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and recommended tenofovir disoproxil fumarate (TDF) + lamivudine (3TC) (or emtricitabine, FTC) + efavirenz (EFV) 600 ...
These consolidated guidelines on preventing and treating HIV infection bring together a series of recommendations to promote the highest quality, person-centred delivery of care for people living with and affected by HIV.
28 Ιαν 2016 · View the recommended strategies to achieve antiretroviral therapy (ART) goals in adults and adolescents with HIV.
3 Ιαν 2023 · This guideline from the International Antiviral (formerly AIDS) Society–USA updates practice recommendations for managing HIV infection including when to initiate antiviral therapy, how to monitor patients’ response, when to change antiviral regimens, and use of preexposure prophylaxis (PrEP) to prevent infection in those at risk.
Objective To evaluate new data and incorporate them into current recommendations for initiating HIV therapy, monitoring individuals starting on therapy, changing regimens, preventing HIV infection for those at risk, and special considerations for older people with HIV.
